AMN Healthcare Services, Inc. (AMN) Financial Ratios
26 years of historical data (2000–2025) · Healthcare · Medical - Care Facilities
EV/EBITDA
↓
10.39
↓-16% vs avg
5yr avg: 12.42
30Y Low6.9·High39.8
P/FCF
↓
5.14
↓-47% vs avg
5yr avg: 9.77
30Y Low2.6·High110.3
P/B Ratio
↓
1.86
↓-39% vs avg
5yr avg: 3.05
30Y Low0.9·High17.3
ROE
↓
-14.2%
↑-214% vs avg
5yr avg: 12.5%
30Y Low-54%·High40%
Debt/EBITDA
↑
4.23
↓-15% vs avg
5yr avg: 4.99
30Y Low0.0·High22.2
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
AMN Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
AMN Healthcare Services, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 5.1x P/FCF, 47% below the 5-year average of 9.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.2B | $607M | $913M | $2.9B | $4.6B | $5.9B | $3.3B | $3.0B | $2.8B | $2.4B | $1.9B |
| Enterprise Value | $2.0B | $1.4B | $2.0B | $4.3B | $5.4B | $6.6B | $4.2B | $3.6B | $3.2B | $2.7B | $2.2B |
| P/E Ratio → | -12.49 | — | — | 13.97 | 10.39 | 17.96 | 46.11 | 25.96 | 19.47 | 18.38 | 17.88 |
| P/S Ratio | 0.44 | 0.22 | 0.31 | 0.78 | 0.88 | 1.48 | 1.36 | 1.33 | 1.29 | 1.22 | 1.00 |
| P/B Ratio | 1.86 | 0.95 | 1.29 | 3.54 | 4.42 | 5.06 | 3.97 | 4.03 | 4.32 | 4.33 | 4.22 |
| P/FCF | 5.14 | 2.60 | 3.81 | 11.04 | 8.05 | 23.35 | 14.95 | 15.74 | 14.47 | 27.44 | 17.24 |
| P/OCF | 4.46 | 2.25 | 2.85 | 7.92 | 7.06 | 19.25 | 12.67 | 13.19 | 12.15 | 21.12 | 14.37 |
P/E links to full P/E history page with 30-year chart
AMN EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
AMN Healthcare Services, Inc.'s enterprise value stands at 10.4x EBITDA, 16% below its 5-year average of 12.4x. The Healthcare sector median is 14.2x, placing the stock at a 27% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.50 | 0.67 | 1.13 | 1.03 | 1.65 | 1.75 | 1.62 | 1.49 | 1.38 | 1.18 |
| EV / EBITDA | 10.39 | 7.25 | 28.14 | 8.54 | 6.90 | 11.28 | 17.17 | 15.31 | 13.05 | 11.19 | 10.15 |
| EV / EBIT | 59.42 | — | — | 12.60 | 8.36 | 13.73 | 28.01 | 20.38 | 15.70 | 12.89 | 11.72 |
| EV / FCF | — | 5.89 | 8.35 | 15.98 | 9.44 | 26.08 | 19.20 | 19.13 | 16.71 | 30.87 | 20.44 |
AMN Profitability
Margins and return-on-capital ratios measuring operating efficiency
AMN Healthcare Services, Inc. earns an operating margin of 1.2%. Operating margins have compressed from 8.9% to 1.2% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -14.2% indicates the company is currently destroying shareholder equity. ROIC of 1.6% represents below-average returns on invested capital.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.3% | 28.3% | 30.8% | 33.0% | 32.7% | 32.9% | 33.1% | 33.5% | 32.6% | 32.4% | 32.6% |
| Operating Margin | 1.2% | 1.2% | -3.4% | 8.9% | 12.3% | 12.0% | 6.2% | 8.0% | 9.5% | 10.7% | 10.1% |
| Net Profit Margin | -3.5% | -3.5% | -4.9% | 5.6% | 8.5% | 8.2% | 3.0% | 5.1% | 6.6% | 6.7% | 5.6% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -14.2% | -14.2% | -19.1% | 22.5% | 40.3% | 33.0% | 9.1% | 16.6% | 23.6% | 26.2% | 26.6% |
| ROA | -4.2% | -4.2% | -5.5% | 7.2% | 14.8% | 11.9% | 3.3% | 6.7% | 10.3% | 10.9% | 10.2% |
| ROIC | 1.6% | 1.6% | -3.9% | 12.7% | 26.3% | 19.9% | 7.2% | 10.9% | 15.7% | 19.1% | 21.2% |
| ROCE | 2.0% | 2.0% | -5.0% | 15.7% | 30.9% | 23.4% | 8.6% | 12.9% | 18.7% | 22.4% | 24.9% |
AMN Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
AMN Healthcare Services, Inc. carries a Debt/EBITDA ratio of 4.2x, which is highly leveraged (32% above the sector average of 3.2x). Net debt stands at $769M ($803M total debt minus $34M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.25 | 1.25 | 1.55 | 1.62 | 0.82 | 0.75 | 1.17 | 0.98 | 0.69 | 0.57 | 0.81 |
| Debt / EBITDA | 4.23 | 4.23 | 15.44 | 2.70 | 1.10 | 1.49 | 3.92 | 3.07 | 1.81 | 1.31 | 1.64 |
| Net Debt / Equity | — | 1.20 | 1.54 | 1.58 | 0.76 | 0.59 | 1.13 | 0.87 | 0.67 | 0.54 | 0.78 |
| Net Debt / EBITDA | 4.05 | 4.05 | 15.29 | 2.64 | 1.02 | 1.18 | 3.80 | 2.72 | 1.75 | 1.25 | 1.59 |
| Debt / FCF | — | 3.29 | 4.54 | 4.94 | 1.39 | 2.73 | 4.25 | 3.39 | 2.24 | 3.43 | 3.21 |
| Interest Coverage | -1.22 | -1.22 | -1.47 | 6.25 | 16.02 | 14.03 | 2.59 | 6.22 | 12.56 | 10.80 | 12.39 |
AMN Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.94x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 1.28x to 0.94x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.94 | 0.94 | 1.09 | 1.28 | 1.27 | 1.39 | 1.26 | 1.48 | 1.57 | 1.79 | 1.64 |
| Quick Ratio | 0.94 | 0.94 | 1.09 | 1.28 | 1.27 | 1.39 | 1.17 | 1.48 | 1.44 | 1.57 | 1.51 |
| Cash Ratio | 0.06 | 0.06 | 0.02 | 0.05 | 0.08 | 0.19 | 0.07 | 0.22 | 0.05 | 0.06 | 0.04 |
| Asset Turnover | — | 1.30 | 1.24 | 1.30 | 1.82 | 1.27 | 1.02 | 1.15 | 1.43 | 1.59 | 1.60 |
| Inventory Turnover | — | — | — | — | — | — | 41.24 | — | 36.41 | 23.21 | 37.22 |
| Days Sales Outstanding | — | 58.70 | 63.61 | 71.91 | 66.36 | 94.25 | 68.63 | 70.86 | 71.22 | 74.78 | 75.13 |
AMN Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
AMN Healthcare Services, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | 7.2% | 9.6% | 5.6% | 2.2% | 3.9% | 5.1% | 5.4% | 5.6% |
| FCF Yield | 19.5% | 38.5% | 26.2% | 9.1% | 12.4% | 4.3% | 6.7% | 6.4% | 6.9% | 3.6% | 5.8% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 14.4% | 12.5% | 0.0% | 0.2% | 0.6% | 2.4% | 0.8% | 0.7% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 14.4% | 12.5% | 0.0% | 0.2% | 0.6% | 2.4% | 0.8% | 0.7% |
| Shares Outstanding | — | $39M | $38M | $39M | $45M | $48M | $48M | $48M | $49M | $49M | $49M |
Peer Comparison
Compare AMN with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 AMNYou | $1B | -12.5 | 10.4 | 5.1 | 28.3% | 1.2% | -14.2% | 1.6% | 4.2 |
 CHE | $6B | 23.7 | 15.0 | 18.3 | 30.0% | 13.4% | 25.3% | 23.7% | 0.4 |
 CCRN | $426M | -4.5 | 24.0 | 10.6 | 18.7% | -0.3% | -25.6% | -0.9% | 0.2 |
 TBI | $203M | -4.2 | 170.2 | — | 21.2% | -1.7% | -16.3% | -5.2% | 83.1 |
 HCSG | $2B | 28.3 | 23.1 | 11.8 | 13.0% | 2.6% | 11.7% | 9.0% | 0.4 |
 MMS | $3B | 10.1 | 5.7 | 8.0 | 23.0% | 10.6% | 18.1% | 15.1% | 2.0 |
 OPCH | $3B | 17.3 | 7.9 | 13.3 | 18.1% | 6.0% | 15.2% | 15.3% | — |
 ADUS | $2B | 18.1 | 12.2 | 16.9 | 32.5% | 9.7% | 9.3% | 8.8% | 1.3 |
 ENSG | $9B | 26.3 | 23.5 | 24.2 | 13.7% | 8.6% | 16.9% | 7.0% | 7.7 |
 UNH | $364B | 30.3 | 17.9 | 22.6 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 |
 HCA | $84B | 13.2 | 8.6 | 10.9 | 41.5% | 15.8% | — | 19.9% | 3.2 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 26 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
AMN — Frequently Asked Questions
Quick answers to the most common questions about buying AMN stock.
What is AMN Healthcare Services, Inc.'s P/E ratio?
AMN Healthcare Services, Inc.'s current P/E ratio is -12.5x. The historical average is 35.9x.
What is AMN Healthcare Services, Inc.'s EV/EBITDA?
AMN Healthcare Services, Inc.'s current EV/EBITDA is 10.4x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 17.7x.
What is AMN Healthcare Services, Inc.'s ROE?
AMN Healthcare Services, Inc.'s return on equity (ROE) is -14.2%. The historical average is 8.6%.
Is AMN stock overvalued?
Based on historical data, AMN Healthcare Services, Inc. is trading at a P/E of -12.5x. Compare with industry peers and growth rates for a complete picture.
What are AMN Healthcare Services, Inc.'s profit margins?
AMN Healthcare Services, Inc. has 28.3% gross margin and 1.2% operating margin.
How much debt does AMN Healthcare Services, Inc. have?
AMN Healthcare Services, Inc.'s Debt/EBITDA ratio is 4.2x, indicating high leverage. A ratio above 4x may signal elevated financial risk.